Preparing for Responsible Sharing of Clinical Trial Data
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The authors review the potential benefits and unintended consequences of the broad sharing of participant-level data from clinical trials. Several options for governance structures that could be implemented to provide expanded access to clinical trial data are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Identifying Personal Genomes by Surname Inference
Gymrek, M., McGuire, A. L., Golan, D., Halperin, E., & Erlich, Y. (2013) · Science · doi:10.1126/science.1229566 · Cited by 1,228
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.3424 · Cited by 516
Empirical Study of Data Sharing by Authors Publishing in PLoS Journals
Savage, C. J., & Vickers, A. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007078 · Cited by 411
Issues in the Registration of Clinical Trials
Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., & Lindberg, D. A. B. (2007) · JAMA · doi:10.1001/jama.297.19.2112 · Cited by 222
The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
Doshi, P., Jefferson, T., & Del Mar, C. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001201 · Cited by 165
Whose data set is it anyway? Sharing raw data from randomized trials
Vickers, A. J. (2006) · Trials · doi:10.1186/1745-6215-7-15 · Cited by 149
Why we need easy access to all data from all clinical trials and how to accomplish it
Gøtzsche, P. C. (2011) · Trials · doi:10.1186/1745-6215-12-249 · Cited by 137
Access to Patient-Level Data from GlaxoSmithKline Clinical Trials
Nisen, P., & Rockhold, F. (2013) · New England Journal of Medicine · doi:10.1056/nejmsr1302541 · Cited by 120
Ushering in a New Era of Open Science Through Data Sharing: The Wall Must Come Down
Ross, J. S., & Krumholz, H. M. (2013) · JAMA · doi:10.1001/jama.2013.1299 · Cited by 118
Malin, B., Karp, D., & Scheuermann, R. H. (2010) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181c9b2ea · Cited by 113
Open Clinical Trial Data for All? A View from Regulators
Eichler, H.-G., Abadie, E., Breckenridge, A., Leufkens, H., & Rasi, G. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001202 · Cited by 105
The Importance of Clinical Trial Data Sharing: Toward More Open Science
Ross, J. S., Lehman, R., & Gross, C. P. (2012) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965798 · Cited by 104
The new BMJ policy on sharing data from drug and device trials
Godlee, F., & Groves, T. (2012) · BMJ · doi:10.1136/bmj.e7888 · Cited by 74
Ethical and Scientific Issues in Studying the Safety of Approved Drugs
Institute of Medicine (2012) · National Academies Press eBooks · doi:10.17226/13219 · Cited by 70
Participant-Level Data and the New Frontier in Trial Transparency
Zarin, D. A. (2013) · New England Journal of Medicine · doi:10.1056/nejme1307268 · Cited by 61
Clinical trial data for all drugs in current use
Godlee, F. (2012) · BMJ · doi:10.1136/bmj.e7304 · Cited by 57
A Model for Dissemination and Independent Analysis of Industry Data
Krumholz, H. M., & Ross, J. S. (2011) · JAMA · doi:10.1001/jama.2011.1459 · Cited by 44
Pharmaceutical Knowledge Governance: A Human Rights Perspective
Lemmens, T. (2013) · The Journal of Law Medicine & Ethics · doi:10.1111/jlme.12012 · Cited by 42
Pharma Firms Push for Sharing of Cancer Trial Data
Bhattacharjee, Y. (2012) · Science · doi:10.1126/science.338.6103.29 · Cited by 40
Missing clinical trial data: setting the record straight
Godlee, F., & Loder, E. (2010) · BMJ · doi:10.1136/bmj.c5641 · Cited by 34
Registering Clinical Trial Results
Miller, J. D. (2010) · JAMA · doi:10.1001/jama.2010.207 · Cited by 32
Restoring Confidence in the Pharmaceutical Industry
Bauchner, H., & Fontanarosa, P. (2013) · JAMA · doi:10.1001/jama.2013.58 · Cited by 32
Making raw data more widely available
Vickers, A. J. (2011) · BMJ · doi:10.1136/bmj.d2323 · Cited by 31
Chan, A.-W. (2011) · BMJ · doi:10.1136/bmj.d80 · Cited by 27
The Double-Edged Sword of Open Access to Research Data
Spertus, J. A. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.965814 · Cited by 25
GlaxoSmithKline opens the door on clinical data sharing
Harrison, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3907 · Cited by 23
Rm, H., Weinstein, M., Pool, R., & Cohen, B. (2013) · Cited by 21
Drug Watchdog Ponders How to Open Clinical Trial Data Vault
Rabesandratana, T. (2013) · Science · doi:10.1126/science.339.6126.1369 · Cited by 17
Califf, R. M. (2012) · JAMA · doi:10.1001/jama.2012.4434 · Cited by 11
Roche says it will not relinquish control over access to clinical trial data
Kmietowicz, Z. (2013) · BMJ · doi:10.1136/bmj.f1374 · Cited by 8
(2012) · Nature Biotechnology · doi:10.1038/nbt.2237 · Cited by 8
Cited by
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Increasing value and reducing waste: addressing inaccessible research
Chan, A.-W., Song, F., Vickers, A., Jefferson, T., Dickersin, K., Gøtzsche, P. C., Krumholz, H. M., Ghersi, D., & van der Worp, H. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62296-5 · Cited by 887
The ethics of big data: current and foreseeable issues in biomedical contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-015-9652-2 · Cited by 714
Drug discovery and development: Role of basic biological research
Mohs, R. C., & Greig, N. H. (2017) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.005 · Cited by 673
“contributes toward the more rapid introduction of new medicines [29,30].”
BackgroundScaling Up Scientific Discovery in Sleep Medicine: The National Sleep Research Resource
Dean, D. A., Goldberger, A. L., Mueller, R., Kim, M., Rueschman, M., Mobley, D., Sahoo, S. S., Jayapandian, C. P., Cui, L., Morrical, M. G., et al. (2016) · Sleep · doi:10.5665/sleep.5774 · Cited by 309
Metadata
- Authors
- Mello, M. M., Francer, J. K., Wilenzick, M., Teden, P., Bierer, B. E., & Barnes, M.
- Affiliations
- Harvard University (US)
- Pharmaceutical Research and Manufacturers of America (US)
- Brigham and Women's Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-10-24
- Volume
- 369
- Issue
- 17
- Pages
- 1651-1658
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2077842152
- Cited by
- 175
- References
- 32
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 13 · 2021: 6 · 2020: 16 · 2019: 11 · 2018: 11 · 2017: 17 · 2016: 23 · 2015: 31 · 2014: 21 · 2013: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Keywords
- clinical trial data sharing, participant-level data, data governance, research ethics, unintended consequences, responsible data sharing
- MeSH terms
- Clinical Trials as Topic, Confidentiality, Registries, United States, Databases, Factual, Information Dissemination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.